strontium ranelate
Selected indexed studies
- Strontium ranelate in post-menopausal osteoporosis. (Endokrynol Pol, 2011) [PMID:21365582]
- Strontium ranelate, a promising disease modifying osteoarthritis drug. (Expert Opin Investig Drugs, 2017) [PMID:28092725]
- Strontium ranelate: a novel mode of action optimizing bone formation and resorption. (Osteoporos Int, 2005) [PMID:15578159]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Strontium ranelate in post-menopausal osteoporosis. (2011) pubmed
- Strontium ranelate, a promising disease modifying osteoarthritis drug. (2017) pubmed
- Strontium ranelate: a novel mode of action optimizing bone formation and resorption. (2005) pubmed
- Strontium ranelate for osteoporosis? (2006) pubmed
- Strontium ranelate: a physiological approach for optimizing bone formation and resorption. (2006) pubmed
- Strontium ranelate: in search for the mechanism of action. (2013) pubmed
- Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review. (2018) pubmed
- Strontium and strontium ranelate: Historical review of some of their functions. (2017) pubmed
- Strontium ranelate for preventing and treating postmenopausal osteoporosis. (2006) pubmed
- Strontium ranelate: a new paradigm in the treatment of osteoporosis. (2004) pubmed